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Summary
HIV-associated nephropathy (HIVAN) is a common complication of HIV-1 infection in patients 
with African ancestry in general and with APOL1 gene risk variants in particular. Although 
collapsing glomerulopathy is considered a hallmark of HIVAN, significant numbers of glomeruli 
in patients with HIVAN also display other variants of focal segmental glomerulosclerosis (FSGS). 
We propose that collapsed glomeruli as well as glomeruli with other variants of FSGS are 
manifestations of HIVAN and their prevalence depends on associated host factors. We explored 
the role of the renin-angiotensin system (RAS) in the manifestation of any specific glomerular 
phenotype in HIVAN. To evaluate the role of the RAS we have used a genetically engineered 
mouse model of HIVAN (Tg26) with two and four copies of angiotensinogen (Agt) gene (Tg26/
Agt2 and Tg26/Agt4). In Tg26/Agt2, 1 out of 6 glomeruli exhibited sclerosed phenotype, whereas 
1 out of 25 glomeruli displayed collapsed phenotype; on the other hand, in Tg26/Agt4, 1 out of 3 
glomeruli exhibited sclerotic phenotype and only 1 out of 7 glomeruli showed collapsed 
phenotype. To inhibit the effect of RAS, Tg26/Agt2 were administered captopril, aliskiren, 
aliskiren plus captopril or aliskiren plus telmisartan by miniosmotic pumps for 4 weeks. In all 
experimental groups there was a significant reduction in percentage of sclerosed glomeruli and 
only minimal reduction in collapsed glomeruli compared to normal saline receiving Tg26/Agt2. 
These findings suggest that the manifestation of the sclerosed phenotype in HIVAN is 
predominantly dependent on activation of the RAS.
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Introduction
HIV-associated nephropathy, which is characterized by a collapsing variant of FSGS and 
micro cystic tubular dilatation (Pardo et., 1984; Rao et al., 1984; Cantor et al., 1991; 
Bourgoignie et al., 1991; Kopp et al., 1992; Sczech et., 2004; Berliner et al., 2008), is a 
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manifestation of specific genetic, environmental, and host factors (Gharavi et al., 2004; 
Chan et al., 2009; Atta, 2010). Recently, APOL1 with polymorphism at G1 and G2 sites 
(risk allele) has been demonstrated to be a risk factor for non-diabetic glomerulosclerosis 
and for HIVAN patients with an African background (Freedman et al., 2010). Since Apol1 
polymorphism contributes to both conventional FSGS and HIVAN, it is likely that some of 
glomeruli will develop sclerotic phenotype in addition to collapsing phenotype in HIVAN. 
This was further supported by epidemiologic studies showing that with the occurrence of 
HIVAN, the incidence of heroin nephropathy (predominantly sclerotic phenotype) has 
disappeared in the patients with African American ancestry (Fiedman et al., 1995). These 
studies suggest a possibility that in patients with HIV infection, the occurrence of sclerotic 
and collapsing lesions may be a part of the spectrum of the same entity - HIVAN.
The pathogenesis of glomerular lesions in HIVAN is characterized by the presence of 
proliferative and apoptosed cells (Atta, 2010). Under any stress, the fate (phenotype) of the 
cellular injury is dependent on the net outcome of forces promoting cell survival vs. cell 
death (Yadav et al., a, 2010). On that account, cells undergoing proliferation will be 
accompanied by some cells having apoptotic phenotype and cells undergoing the apoptotic 
process will be accompanied by some proliferating cells (Yadav et al., b, 2010). 
Nonetheless, the net outcome is defined by a net increase or decrease in the number of cells. 
Thus, theoretically, it is possible that during the time course of the disease there will be an 
increase or decrease in the severity of HIV-induced kidney cell injury depending on viral, 
genetic and host factors which will determine the emergence of a specific glomerular 
phenotype - sclerotic vs. collapsing. Since proliferating and apoptosed cells are the outcome 
of the loss of their native phenotype, it becomes difficult to determine the cell lineage. On 
that account, the exact lineage of proliferating cells in the Bowman’s space in collapsing 
variant of glomerulosclerosis still remains controversial (Barisoni et al., 2002; Dijkman et 
al., 2005; Dijkman et al., 2006). Several investigators suggested the lineage of glomerular 
proliferating cells to be of parietal cell origin rather than of visceral epithelial cells (Dijkman 
et al., 2005; Dijkman et al., 2006). However, we suggested that determination of the lineage 
of these cells depends on their location and the outcome of ongoing epithelial mesenchymal 
transition (Yadav et al., b, 2010).
The collapsing variant of glomerulosclerosis is characterized by segmental or global 
obliteration of the glomerular capillary lumina by wrinkling and collapse of the glomerular 
basement membrane associated with podocyte hypertrophy and hyperplasia (D’Agati., 
2003). It has been shown in clinical studies that HIV and non-HIV patients with collapsing 
glomerulopathy develop higher rates of proteinuria and an accelerated decline in kidney 
function (Weiss et al., 1986; Valeri et al., 1996). Howie et al. (2001) suggested a method for 
measurement of chronic damage in renal biopsy specimens which proved to be prognostic in 
predicting renal survival in patients with chronic kidney diseases, including HIVAN (Howie 
et al., 2001; Post et al., 2008). Based on these studies, we separated HIVAN mice into two 
groups: severe disease and mild disease, depending on the percentage of glomeruli with 
global sclerosis and number of micro cystic tubular dilatations. We asked whether the 
presence of collapsed glomeruli in HIVAN is itself an independent marker of severity of the 
disease; in that scenario, the number of sclerotic glomeruli to one collapsed glomerulus has 
to increase with the severity of HIVAN. To test our hypothesis we evaluated the effects of 
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RAS activation and down regulation on the prevalence of sclerosed vs. collapsed glomeruli 
in a transgenic mouse model of HIVAN. We also attempted to predict the probability of 
having an adequate biopsy specimen with sclerosed vs. collapsed glomeruli for the diagnosis 
of HIVAN.
Materials and methods
HIV transgenic mice (Tg26)
We have used Tg26 (with FVB/N background) mice. Breeding pairs to develop Tg26 
colonies were kindly gifted by Prof. Paul E. Klotman M.D., President and CEO, Baylor 
College of Medicine, Houston, TX. Tg26 transgenic animals have the proviral transgene, 
pNL4-3: d1443, which encodes all the HIV-1 genes except gag and pol and therefore the 
mice are noninfectious (Lu et al., 2006). We are maintaining colonies of these mice in our 
animal facility. For genotyping, tail tips were clipped, DNA was isolated and PCR studies 
were carried out using following primers for Tg26.
HIV-F 5′ ACATGAGCAGTCAGTTCTGCCGCAGAC
HIV-R 3′ CAAGGACTCTGATGCGCAGGTGTG
The experimental protocol was approved by the Ethics Review Committee for Animal 
Experimentation of Long Island Jewish Medical Center.
Angiotensinogen (Agt) Transgenic Mice
We obtained Agtdup/Agtdup mice from Jackson Laboratories, Bar Harbor (ME). Since these 
mice were not on an FVB/N background, we have bred them with FVB/N for eight 
generations. Homozygous Agt mice (Agtdup/Agtdup) are viable and fertile. They show blood 
pressure levels ~16 mm Hg higher than their normal wild-type siblings (Agt+/Agt+). 
Heterozygous mice (Agt+/Agtdup) show blood pressure levels ~8 mm Hg higher than their 
normal wild-type siblings. This transgenic mouse model demonstrates the causality between 
genotype at the angiotensinogen locus and blood pressures. Blood pressures of one-copy 
(Agttm1Unc/+) through four-copy (Agtdup/Agtdup) animals show significant and almost linear 
increases of approximately 8 mm Hg per gene copy despite their normal compensatory 
mechanisms being intact.
To generate Tg26 mice with variable Agt copies, Tg26 mice were bred with Agtdup/Agtdup 
mice. Genotyping assays to distinguish between the different allele of the Agt gene (Agt+ 
and Agtdup) have been established at the Jackson Laboratory. The tail DNA of the progeny 
was analyzed by PCR. The Agtdup allele produced a 190-bp fragment when amplified with 
the D8Mit56 marker, whereas Agt+ gave a 160-bp fragment. The sequences of the two 
primers that were used are as follows: 5′-ACACTCAGAGACCATGAGTACACC-3′ SSLP 
primer D11Mit 258 and 5′-GAGTTCACTACCCACAAGTCTCC-3′ SSLP primer 
D11Mit258. Twelve week old Tg26 mice (8 in each group) with 2 and 4 copies of Agt were 
used for renal histology scoring.
To determine the effect of down regulation of the RAS on HIVAN, Tg26 mice (in groups of 
four) were administered either normal saline, angiotensin converting enzyme (ACE) 
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inhibitor, Captopril (5 mg/Kg body weight/day); inhibitor of renin activity, Tekturna 
(Tekturna, 50mg/Kg body weight/day); a combination of Tekturna and Captopril; and a 
combination of Tekturna with angiotensin receptor (AT1) blocker, Telmisartan (300 μg/day, 
calculated for average weight of the mouse) via miniosmotic pumps for four weeks.
Renal Histology
At the end of the experimental periods, mice were sacrificed, mouse kidneys were isolated 
and prepared for histology and immunohistochemistry, and blood and urine samples were 
collected for biomarker assay. Renal cortical sections were stained with hematoxylin and 
eosin (H&E), and periodic acid-Schiff (PAS) stain. Slides were coded and examined under 
light microscopy by two investigators. Twenty random fields per section were examined and 
scored for glomerular lesions and micro cystic tubular dilatations. Glomerular lesions were 
classified as segmental glomerular sclerosis, SGS (including focal segmental glomerular 
sclerosis not otherwise specified, perihilar variant, tip variant), global glomerular sclerosis 
(GGS), and collapsing glomerulopathy (CG). Microcysts were considered tubules that are 
dilated at least 3-fold compared to normal tubules. The term sclerosis was used in aggregate 
for both segmental and global sclerosis since we believe that segmental sclerosis eventually 
leads to global sclerosis and these glomerular lesions are in the spectrum of the same disease 
process. Moreover, the same glomerulus at another level may show segmental or global 
sclerosis.
Statistical Analysis
For comparison of mean values between two groups, the unpaired t-test was used. To 
compare values between multiple groups, analysis of variance and a Bonferroni multiple 
range test was used to calculate a P value. Statistical significance was defined as P < 0.05.
Results
Tg26 animals develop kidney lesions typical of HIVAN and endogenous RAS activation 
results in glomerular sclerosis
Tg26 is the most frequently used mouse model of HIV-associated nephropathy. These 
animals develop histological changes typical of patients with HIVAN (Figure 1), which 
were shown in previous studies (Pardo et., 1984; Rao et al., 1984; Cantor et al., 1991; 
Bourgoignie et al., 1991; Kopp et al., 1992; Sczech et., 2004; Berliner et al., 2008). In the 
present study we show that the prevalence of different types of glomerular lesions (sclerotic 
vs. collapsing) depends on RAS status (Figure 2). Renal cortical sections of twelve week old 
Tg26 mice with four copies of the angiotensinogen (Agt) gene (Tg26/Agt4) showed a higher 
percentage of sclerosed glomeruli when compared to Tg26 mice with two copies of the Agt 
gene (Tg26/Agt2), whereas the difference in percent of collapsed glomeruli was not 
statistically significant (p>0.05).
Tg26 mice with RAS inhibition show less glomerulosclerosis and improved kidney 
function
In order to down regulate RAS, we administered Captopril, Tekturna or combinations of 
Captopril plus Tekturna, and Tekturna plus Telmisartan to Tg26 mice for four weeks. The 
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percentage of sclerosed glomeruli drastically decreased in treatment groups compared to 
Tg26 mice receiving normal saline. The percentage of collapsing glomeruli did not show a 
significant difference in animals receiving Captopril or Tekturna alone, but more aggressive 
RAS inhibition by the combinations of Captopril plus Tekturna and Tekturna plus 
Telmisartan resulted in a significant decrease in collapsing glomeruli as well (Figure 3).
Along with a decrease in percentage of sclerosed glomeruli, RAS inhibition also resulted in 
improved kidney function which was reflected in lower levels of blood urea nitrogen (BUN) 
compared to control group (Figure 4).
Tg26/Agt4 mice have larger glomeruli comparing to Tg26/Agt2 mice
The size of glomeruli has been shown to be correlated with the progression of FSGS in 
many animal models and in humans (Barisoni et al., 2002; Dijkman et al., 2005; Dijkman et 
al., 2006). We explored the correlation of glomerular size with activation of RAS in Tg26 
mice. Our data show that glomeruli of Tg26/Agt4 mice are 30% larger than those of Tg26/
Agt2 mice (Figure 5).
Discussion
The present study demonstrates that HIVAN is accompanied by both sclerotic and 
collapsing glomerular lesions in HIV transgenic mice; nonetheless, the number of sclerosed 
glomeruli is many times greater than the number of collapsed glomeruli. A higher number of 
Agt copies in HIVAN mice displayed a greater percentage of sclerosed glomeruli, while 
down regulation of the RAS was associated with reduced number of sclerosed glomeruli. 
These findings indicate that the number of sclerosed glomeruli have a higher correlation to 
the activation of RAS than to the number of collapsed glomeruli. The ratio of sclerosed to 
collapsed glomeruli was higher in HIVAN mice with two Agt copies when compared to 
HIVAN mice with four Agt copies. However, down regulation of RAS with ACE, ARBs 
and renin inhibitors attenuated the progression of sclerotic lesions more effectively when 
compared to that of collapsed glomerular lesions.
Since Tg26 mice with 2 Agt copies also displayed sclerosed glomeruli in addition to 
collapsed glomeruli, it was likely that sclerosis was a manifestation of a viral induced 
podocytopathy. Nonetheless, Tg26 mice with 2 Agt copies are also likely to have de novo 
activation of the renin angiotensin system. It has been reported that HIV has the potential to 
stimulate renin generation by podocytes (Salhan et al., 2012); this effect of HIV has been 
attributed to its down regulating effect on liganded vitamin D receptor. Secondly, HIVAN is 
a proteinuric disease leading to hypoproteinemia and hypovolemia, which would also 
enhance activation of the renin angiotensin system. Moreover, Ang II has been demonstrated 
to promote podocyte apoptosis in both in vitro and in vivo studies (Bird et al., 1989; Burns et 
al., 1999). On that account, both attenuation of production of Ang II by captopril as well as 
Ang II blockade have been reported to slow down the progression of renal lesions in Tg26 
mice and HIVAN patients (Ding et al., 2002; Jia et al., 2008). To amplify the role of the 
renin angiotensin system we have used Tg26 mice with variable Agt copies.
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The renin angiotensin system has been demonstrated to play an important role in the 
development and progression of renal lesions (Egido, 1996; Matsusaka et al., 1996). 
Modalities which either inhibit the generation of Ang II or block the effects of Ang II have 
been demonstrated to slow down the progression of HIVAN in both animal experimental 
models and humans (Bird et al., 1989; Burns et al., 1999; Kimmel et al., 2003). 
Additionally, inhibition of renin was also associated with retardation of the progression of 
HIVAN (Kumar et al., 2012). Moreover, infusion of Ang II in a mouse model of HIVAN 
accelerated the progression of HIVAN (Ideura et al., 2007). Furthermore, the activation of 
the RAS converted clinically occult HIVAN to overt HIVAN (Kumar et al., 2011). In the 
present study, too, the activation of the RAS in Tg26 mice was associated with more 
advanced renal lesions in the form of a higher number of sclerosed glomeruli. Interestingly, 
inhibition of the RAS predominantly reduced the number of sclerosed glomeruli.
In the present study, we observed a positive correlation between the number of Agt copies, 
the percentage of sclerosed glomeruli, and glomerular size. Tg26/Agt4 mice displayed 
glomeruli which were 30% larger than those of Tg26/Agt2 mice. Other investigators also 
reported an increase in glomerular volume in FSGS (Young et al., 2000; Hughson et al., 
2002). It has been suggested that renal injury results in stimulation of compensatory growth 
stimuli in hyperperfusion of relatively preserved glomeruli, causing enlarged glomeruli. 
Since hyperperfusion of glomeruli is also the manifestation of the activation of the RAS, an 
increase in the number of larger glomeruli in mice with 4 Agt copies is consistent with our 
hypothesis. On the basis of this hypothesis, we speculate that enlarged glomeruli in mice 
with 4 Agt copies are destined to sclerose.
To make the diagnosis of HIVAN, one has to carry out a kidney biopsy (Atta, 2010). The 
average number of glomerular profiles required for a biopsy specimen to be considered 
adequate ranges from five to ten (Fuiano et al., 1996; Fogo, 2003; Hoy et al., 2006). Out of 
10 profiles at least one has to be sclerosed in order for the diagnosis to be made, which 
makes 10% of the glomeruli. Because the number of sclerosed glomeruli is dependent on the 
severity of the disease we grouped mice according to severity of their glomerular disease: A) 
mice with less than 10% of sclerosed glomeruli and B) mice with ten or more percent of 
sclerosed glomeruli. Thirty three percent of mice belonged to group A and 67% to group B. 
In terms of biopsy specimens, 33% of mice would have no sclerosed glomeruli if the 
specimen contained a total of 10 or less glomerular profiles. In group B, 27% of glomeruli 
or one in every 3.7 were sclerosed and 7% of glomeruli or one in every 14 were collapsed 
(animals from group A were not considered because of negligible number of collapsed 
glomeruli in those mice, 0.6%). This means that the chances of having a sclerosed 
glomerulus in a biopsy sample are 3.7 times higher than having a collapsed one. In order to 
decide the diagnosis of collapsing glomerulopathy, there has to be at least one glomerulus 
showing collapsed glomerular capillaries along with podocyte hypertrophy and hyperplasia. 
These findings point out those that sclerosed glomeruli in the presence of microcystic 
dilatation of tubules may also be the manifestation of HIV-induced podocytopathy.
Based on our data and results, it appears that the number of sclerosed glomeruli correlate 
with the activation of the RAS in HIVAN. In terms of diagnosis of HIV-induced 
podocytopathy via biopsy specimen, there is more likelihood to find a sclerosed glomerulus 
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than a collapsed one. On the other hand, during advanced HIV-induced podocytopathy there 
is more likelihood to have both collapsed and sclerosed glomeruli.
The presence of a single collapsed glomerulus qualifies for the diagnosis of HIVAN and the 
presence of sclerosed glomeruli does not alter its importance. However, data in the present 
study suggest that sclerosed glomeruli may also be part of a viral induced podocytopathy 
and more so in the presence of the activated renin angiotensin system. In that scenario the 
presence of FSGS needs to be considered to be part of a viral induced podocytopathy, more 
so if they are associated with microcystic dilatation of tubules.
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Figure 1. Representative microphotographs displaying glomerular phenotype.
A. A normal glomerulus in a control (FVB/N) mouse.
B. A collapsed glomerulus in Tg26 mouse. There is collapsed glomerular tuft (brown 
arrows), podocyte hypertrophy and hyperplasia (black arrows).
C. Segmental glomerulosclerosis in a Tg26 mouse. Segmental obliteration of glomerular tuft 
by increased matrix and hyaline material (black arrows). PAS; Mag X400
D. A renal cortical section from Tg26 mouse (Agt2) displaying presence of a 
hypercellularity in Bowman’s space with collapsed capillary loops (brown arrows), a 
glomeruls with sclerosed capillary tufts (black arrows) and a normal glomerulus 
(arrowhead). PAS; Mag X 1000
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Cumulative renal histology data of twelve week old Tg26/Agt2 and Tg26/Agt4 mice. 
Animals with four Agt copies displayed 38% of sclerosed glomeruli vs. 17% of sclerosed 
glomeruli in mice with two Agt copies. *<0.05 vs. respective Agt2; **P<0.05 vs. respective 
Agt2.
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Cumulative data of renal histology in mice administered normal saline, captopril, tekturna, 
tekturan + captopril, and tekturna + telmisartan via miniosmotic pumps for four weeks. 
*P<0.05 vs. respective N/Saline groups.
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Blood urea nitrogen data of Tg26 mice treated with normal saline, Captopril, Tekturna, 
Tekturna plus Captopril and Tekturna plus Telmisartan. *P<0.05 vs. Saline.
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Figure 5. Glomerular volume in Tg26Agt2 and Tg26Agt4 mice. A.
A representative unsclerosed glomerulus in Agt2 group.
B. A representative unsclerosed glomerulus in Agt4 group.
C. Cumulative data of glomerular volume in twelve weeks old Tg26/Agt2 and Tg26/Agt4 
mice.
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